RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Amedisys Stock

Amedisys Revenue 2024

Amedisys Revenue

2.4 B USD

Ticker

AMED

ISIN

US0234361089

WKN

915582

In 2024, Amedisys's sales reached 2.4 B USD, a 7.09% difference from the 2.24 B USD sales recorded in the previous year.

The Amedisys Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e2.8135,33
2025e2.5438,98
2024e2.441,37
20232.2444,31
20222.2243,71
20212.2145,83
20202.0742,78
20191.9641,18
20181.6640,28
20171.5140,22
20161.4241,21
20151.2843,31
20141.242,63
20131.2542,53
20121.4443,73
20111.4247,09
20101.650,41
20091.4852,47
20081.1952,62
20070.752,86
20060.5453,39
20050.3857,26
20040.2357,68

Amedisys Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Amedisys, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Amedisys from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Amedisys’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Amedisys. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Amedisys’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Amedisys’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Amedisys’s growth potential.

Amedisys Revenue, EBIT and net profit per share

DateAmedisys RevenueAmedisys EBITAmedisys Net Income
2026e2.81 B undefined285.55 M undefined180.5 M undefined
2025e2.54 B undefined249.49 M undefined170.4 M undefined
2024e2.4 B undefined226.68 M undefined155.69 M undefined
20232.24 B undefined193.07 M undefined-9.75 M undefined
20222.22 B undefined192.8 M undefined118.6 M undefined
20212.21 B undefined272.6 M undefined209.1 M undefined
20202.07 B undefined189.1 M undefined183.6 M undefined
20191.96 B undefined179 M undefined126.8 M undefined
20181.66 B undefined155.1 M undefined119.3 M undefined
20171.51 B undefined108.5 M undefined30.3 M undefined
20161.42 B undefined61.7 M undefined37.3 M undefined
20151.28 B undefined68.1 M undefined-3 M undefined
20141.2 B undefined27.1 M undefined12.8 M undefined
20131.25 B undefined4.5 M undefined-96.2 M undefined
20121.44 B undefined53.2 M undefined-83.6 M undefined
20111.42 B undefined110.8 M undefined-382.5 M undefined
20101.6 B undefined211.3 M undefined112.6 M undefined
20091.48 B undefined238.1 M undefined135.8 M undefined
20081.19 B undefined157.1 M undefined86.7 M undefined
2007697.9 M undefined96.6 M undefined65.1 M undefined
2006541.1 M undefined65.7 M undefined38.3 M undefined
2005381.6 M undefined50.1 M undefined30.1 M undefined
2004227.1 M undefined33.4 M undefined20.5 M undefined

Amedisys stock margins

The Amedisys margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Amedisys. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Amedisys.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Amedisys's sales revenue. A higher gross margin percentage indicates that the Amedisys retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Amedisys's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Amedisys's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Amedisys's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Amedisys. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Amedisys's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Amedisys Margin History

Amedisys Gross marginAmedisys Profit marginAmedisys EBIT marginAmedisys Profit margin
2026e44.31 %10.18 %6.43 %
2025e44.31 %9.81 %6.7 %
2024e44.31 %9.46 %6.5 %
202344.31 %8.63 %-0.44 %
202243.71 %8.67 %5.33 %
202145.83 %12.31 %9.44 %
202042.78 %9.13 %8.86 %
201941.18 %9.15 %6.48 %
201840.28 %9.33 %7.18 %
201740.22 %7.18 %2 %
201641.21 %4.35 %2.63 %
201543.31 %5.32 %-0.23 %
201442.63 %2.25 %1.06 %
201342.53 %0.36 %-7.7 %
201243.73 %3.69 %-5.8 %
201147.09 %7.81 %-26.97 %
201050.41 %13.2 %7.03 %
200952.47 %16.04 %9.15 %
200852.62 %13.23 %7.3 %
200752.86 %13.84 %9.33 %
200653.39 %12.14 %7.08 %
200557.26 %13.13 %7.89 %
200457.68 %14.71 %9.03 %

Amedisys Aktienanalyse

What does Amedisys do?

Amedisys Inc is a US home healthcare provider that offers a variety of healthcare services in the private home, including home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. The company was founded in 1982 by William F. Borne and Michael J. Borne and is headquartered in Baton Rouge, Louisiana. History In the 1980s, while William and Michael Borne were running a nursing home together, they recognized a demand for home healthcare and founded Amedisys in 1982. The company started with a small group of nurses making house calls and was based on the belief that people would prefer to be cared for at home rather than being placed in a facility. In 1999, Amedisys was acquired by the American Stock Exchange and was able to steadily improve its performance and expand its business model to multiple states. In 2007, the company went public and has been listed on NASDAQ since. Business Model Amedisys offers a wide range of healthcare services that are typically received by patients at home. The services include home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. Amedisys collaborates with over 360 medical faculties and over 7,500 medical professionals who provide healthcare to over 385,000 patients per year. Amedisys also offers training programs for nurses and other employees to discover the business and potential growth opportunities. The company relies on teamwork to motivate staff and keep their knowledge and skills up-to-date. Segments Amedisys operates in two main business segments: home healthcare and hospice care. Both segments offer specialized services and are provided by professionals such as registered nurses, therapists, medical assistants, and social workers. The company has more than 435 hospice facilities in 34 US states and over 197 home healthcare branches in 38 US states. Products Amedisys offers a variety of products, including infusion therapy, professional wound management, clinical respiratory therapy, polypharmacy management, specialized care services, and palliative care. The company also provides telemedicine options for patients to receive care from home. Summary Amedisys is a leading provider of home healthcare and hospice care in the US. The company offers a wide range of services and is able to serve both the inpatient and outpatient settings. The company relies on teamwork to provide comprehensive and high-quality care to patients. Amedisys is a successful and expanding company that is also exploring new market potentials through the use of technology. Amedisys ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Amedisys's Sales Figures

The sales figures of Amedisys originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Amedisys’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Amedisys's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Amedisys’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Amedisys stock

How much revenue did Amedisys generate this year?

Amedisys has achieved a revenue of 2.4 B USD this year.

How much was the turnover of the company Amedisys compared to the previous year?

The revenue of Amedisys has increased by 7.09% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Amedisys?

The revenue of Amedisys is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Amedisys measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Amedisys so important for investors?

The revenue of Amedisys is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Amedisys pay?

Over the past 12 months, Amedisys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amedisys is expected to pay a dividend of 0 USD.

What is the dividend yield of Amedisys?

The current dividend yield of Amedisys is .

When does Amedisys pay dividends?

Amedisys pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amedisys?

Amedisys paid dividends every year for the past 0 years.

What is the dividend of Amedisys?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amedisys located?

Amedisys is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amedisys kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amedisys from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Amedisys pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Amedisys in the year 2023?

In the year 2023, Amedisys distributed 0 USD as dividends.

In which currency does Amedisys pay out the dividend?

The dividends of Amedisys are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Amedisys stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Amedisys

Our stock analysis for Amedisys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.